Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology|December 1, 2004
Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanerceptBoulos Haraoui, Edward C Keystone, J Carter Thorne, et al.
ACR Open Rheumatology|November 29, 2019
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 YearsJanet E Pope, Edward Keystone, Shahin Jamal, et al.
Advances in Rheumatology (London, England)|June 24, 2026
CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-worldJanet E Pope, John S Sampalis, Boulos Haraoui, et al.
Annals of the Rheumatic Diseases|May 10, 2011
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observationJean-Pierre Raynauld, Johanne Martel-Pelletier, Boulos Haraoui, et al.
Rheumatology Advances in Practice|August 11, 2021
Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)Peter C Taylor, Robin Christensen, Shahrzad Moosavi, et al.
Clinical Rheumatology|December 11, 2017
Defining and characterizing sustained remission in patients with rheumatoid arthritisJeffrey R Curtis, Mona Trivedi, Boulos Haraoui, et al.
Rheumatology (Oxford, England)|June 23, 2016
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis CohortCarol A Hitchon, Gilles Boire, Boulos Haraoui, et al.
The Journal of Rheumatology|September 4, 2012
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH studyLonnie Pyne, Vivian P Bykerk, Gilles Boire, et al.
The Journal of Rheumatology|May 17, 2011
Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trialDafna D Gladman, Claire Bombardier, Carter Thorne, et al.
The New England Journal of Medicine|October 14, 2020
Trial of Upadacitinib or Abatacept in Rheumatoid ArthritisAndrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, et al.
Pageof 14